Abstract

Artesunate (ART) has anti-cancer activities for a variety of solid tumors. The aim of this study was to investigate the anti-metastatic effect of ART on cervical cancer cells. In vivo anti-metastatic effect of ART was investigated in mice with the lung metastasis model by the subcutaneous injection of ART. The interaction of HOTAIR and COX-2 was measured by RNA immunoprecipitation and RNA pull-down assay. The effect of ART on metastasis of CaSki and Hela cells was evaluated by invasion and migration assay. We found that ART inhibited cervical cancer metastasis and HOTAIR expression. HOTAIR overexpression partially abolished the anti-metastatic effect of ART on cervical cancer cells. In addition, HOTAIR can interact with COX-2 to positively regulate COX-2 expression and catalytic activity. Finally, overexpression of COX-2 reversed the effect of HOTAIR knockdown on Hela cell migration and invasion. Taken together, our data revealed that ART may elicit anti-metastatic effect against cervical cancer by inhibition of HOTAIR expression, which resulted in the decrease of COX-2 expression.

Highlights

  • Cervical cancer is a leading cause of cancer-related death among females worldwide, in developing countries [1]

  • We have found that HOTAIR expression was significantly inhibited in cervical cancer cells induced by ART

  • Our results showed that ART significantly decreased HOTAIR expression in cervical cancer cells (Fig 2B)

Read more

Summary

Introduction

Cervical cancer is a leading cause of cancer-related death among females worldwide, in developing countries [1]. The 5-year survival rate is about 90% if patients were treated in the early stages. Patient outcome is poor when the cancer has metastasized [2]. The traditional strategies for the treatment including surgery, radiotherapy and chemotherapy are not effective to metastatic patients and have severe side effects [3]. There is a renewed interest in the use of natural sources to treat cervical cancer.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call